Safety of Growth Hormone and Cardiovascular Outcomes in Patients With Noonan Syndrome Enrolled in Nordinet (R) International Outcome Study (IOS) and the ANSWER Program
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
9-2021
Journal Title
Hormone Research in Paediatrics
Department
Pediatrics
Recommended Citation
Romano, A., Kaski, J. P., Dahlgren, J., Kelepouris, N., Pietropoli, A., Rohrer, T. R., & Polak, M. (2021). Safety of Growth Hormone and Cardiovascular Outcomes in Patients With Noonan Syndrome Enrolled in Nordinet (R) International Outcome Study (IOS) and the ANSWER Program. Hormone Research in Paediatrics, 94 (Suppl. 1), 160-161. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/541
COinS